We restart the publication of #clinicaldata for all medicines 💊 as of Sept '23.
‼️Save the date for a webinar we are organising to guide pharma industry, including small & medium-sized enterprises, on the submission of clinical data for publication. https://www.ema.europa.eu/en/events/clinical-data-publication-policy-0070-re-launch-ema-webinar

🐦🔗: https://n.respublicae.eu/EMA_News/status/1654018123211718657

EMA routinely publishes #ClinicalData supporting the marketing authorisations and #safety monitoring of #COVID19medicines.

We are the 1⃣st regulatory authorities in the world with @GovCanHealth 🇨🇦 to provide such broad online access to clinical data.

#Transparency

🐦🔗: https://n.respublicae.eu/EMA_News/status/1635648718652207106

EMA routinely publishes #ClinicalData supporting the marketing authorisations and #safety monitoring of #COVID19medicines.

We are the 1⃣st regulatory authorities in the world with @GovCanHealth 🇨🇦 to provide such broad online access to clinical data.

#Transparency

🐦🔗: https://n.respublicae.eu/EMA_News/status/1605588193243439105

💡 The European Medicines Agency (EMA) routinely publishes #ClinicalData supporting the marketing authorisations and #safety monitoring of #COVID19 medicines and #vaccines.

https://clinicaldata.ema.europa.eu/web/cdp/home

EMA routinely publishes #ClinicalData supporting the marketing authorisations and #safety monitoring of #COVID19medicines.

We are the 1⃣st regulatory authorities in the world with @GovCanHealth 🇨🇦 to provide such broad online access to clinical data.

#Transparency

🐦🔗: https://nitter.eu/EMA_News/status/1592105049546694656

RT @EMA_News: EMA has published #ClinicalData supporting the possibility of administering Spikevax #Covid19vaccine together with a dose of #flu vaccine.

👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EU_Health/status/1589565141838082048

EMA has published #ClinicalData supporting the possibility of administering Spikevax #Covid19vaccine together with a dose of #flu vaccine.

👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EMA_News/status/1589557859884290048

RT @EMA_News: EMA has published #ClinicalData supporting the possibility of administering Spikevax #Covid19vaccine together with a dose of #flu vaccine.

👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/ECDC_EU/status/1589565887472087040

EMA has published #ClinicalData supporting the authorisation of the adapted #Comirnaty #COVID19vaccine targeting the #Omicron subvariant BA.1.
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EMA_News/status/1585908498499444736

📢Just published ❗️ - #ClinicalData supporting the use of #Comirnaty as a #BoosterDose for children aged 5 to 11 are now available.
@GovCanHealth
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EMA_News/status/1584928181626097667

RT @EMA_News: EMA has published #ClinicalData supporting the authorisation of the adapted #Comirnaty #COVID19vaccine targeting the #Omicron subvariant BA.1.
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/ECDC_EU/status/1585911633511174144

RT @EMA_News: EMA has published #ClinicalData supporting the authorisation of the adapted #Comirnaty #COVID19vaccine targeting the #Omicron subvariant BA.1.
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EU_Health/status/1585913816268808193

RT @EMA_News: 📢Just published ❗️ - #ClinicalData supporting the use of #Comirnaty as a #BoosterDose for children aged 5 to 11 are now available.
@GovCanHealth
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/ECDC_EU/status/1585172673427931136

RT @EMA_News: 📢Just published ❗️ - #ClinicalData supporting the use of #Comirnaty as a #BoosterDose for children aged 5 to 11 are now available.
@GovCanHealth
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EU_Health/status/1585153093414494208

EMA’s recommendation on BA.4/5 adapted Comirnaty vaccine is based on a totality of evidence. #ClinicalData for one #AdaptedVaccine helps to evaluate other adapted vaccines. Comirnaty Original/Omicron BA.1 & Comirnaty Original/Omicron BA.4/5 have essentially the same composition.

🐦🔗: https://nitter.eu/EMA_News/status/1572217299335086081

RT @EMA_News: EMA has published #ClinicalData on the use of a #boosterdose of #Spikevax in adolescents aged 12 to 18 years old.
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/ECDC_EU/status/1564195913630982144

EMA has published #ClinicalData on the use of a #boosterdose of #Spikevax in adolescents aged 12 to 18 years old.
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EMA_News/status/1564188212670652417

RT @EMA_News: EMA has published #ClinicalData on the use of a #boosterdose of #Spikevax in adolescents aged 12 to 18 years old.
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EU_Health/status/1564192167811317764

EMA has published #ClinicalData on the efficacy, safety and tolerability of #Comirnaty in adolescents aged 12 to 15 after a 6-months follow-up from the 2nd dose.
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EMA_News/status/1554030733013958656

EMA has published #ClinicalData supporting a #boosterdose of #Comirnaty in adults who received a different #COVID19vaccine during their initial course of vaccination.
@GovCanHealth
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EMA_News/status/1550052309098536962